Is psilocybin legal in Maine in 2026?

LD 1034 did not become law

The Legislature's official bill page records the final disposition of LD 1034 as “Enactment Failed” on June 10, 2025. The proposal would have changed the treatment of certain personal possession under Maine law, but the failed bill changed nothing.

LD 1034 did not create a study commission or advisory board. Maine therefore has no commission report deadline, regulated psilocybin-services program, licensing process, launch date, or implementation schedule to track from this bill.

Maine's psychedelic reform efforts: the full legislative history

LD 1034 was not Maine's first attempt to loosen psilocybin law. Two separate bills reached the Legislature in consecutive sessions, plus a city-level resolution. None changed state law. Knowing the difference between them matters, because the two bills are easy to conflate — and conflating them is the source of a recurring factual error on this topic.

LD 1914 (2023–2024): the legalization bill that became a study commission

LD 1914, "An Act to Enact the Maine Psilocybin Health Access Act," was introduced in the 131st Legislature in May 2023. As originally drafted, it was a full legalization bill: it would have created a regulated framework to provide psilocybin products to adults 21 and older, including licensed service centers, a Maine Psilocybin Advisory Board, and rulemaking by the Department of Health and Human Services.

During committee, the bill was amended by striking everything after the title and substituting a far narrower measure: "Resolve, to Establish the Commission to Study Pathways for Creating a Psilocybin Services Program in Maine." The amended version would have created a 13-member study commission to report to the Joint Standing Committee on Veterans and Legal Affairs.

Even that scaled-back study commission never became law. The Legislature's official record shows LD 1914 reported out with a divided committee vote (Ought To Pass As Amended / Ought Not To Pass) on April 3, 2024, and the bill died when the 131st Legislature concluded. No commission was ever seated, and no commission report was ever produced.

This is the source of a common error. Because LD 1914 was amended into a "Commission to Study Pathways for Creating a Psilocybin Services Program," some accounts incorrectly attribute that commission to LD 1034, or claim a Maine psilocybin commission is currently operating with a pending report. Both claims are false. The commission existed only as unenacted legislative text in LD 1914; LD 1034 (the next session's bill) contained no commission at all.

LD 1034 (2025): the narrow decriminalization bill

In the 132nd Legislature, LD 1034, sponsored by Rep. Grayson Lookner (D-Portland), took a narrower approach than LD 1914. Rather than building a regulated market or a study commission, it would have simply decriminalized personal possession of one ounce or less of psilocybin for adults 21 and older — removing criminal penalties without authorizing production, sales, or services.

It passed initial votes in both chambers by a single vote (House 70–69 on June 2, 2025; Senate 17–16 on June 3) but failed final enactment (House 72–74 on June 9; Senate deadlocked 16–16 on June 10) and was marked dead on June 10, 2025. It created nothing that is now operating.

Portland's 2023 resolution: non-binding, city-level only

Separately from state legislation, the Portland City Council passed a resolution on October 2, 2023 (6–3) directing that enforcement of laws against psychedelic plants and fungi be among the city's lowest law-enforcement priorities. The resolution is a statement of council opinion only — it is non-binding, directs no city official, and did not change any law. City officials confirmed at the time that a binding ordinance would be required to make decriminalization enforceable, and no such ordinance was enacted. State law still applies in Portland, and state and federal authorities are not bound by the resolution.

Where things stand in 2026

As of 2026, Maine has no state psilocybin decriminalization, no regulated services program, no operating study commission, and no active psilocybin bill in the current legislative session. Psilocybin possession remains a Class D crime under state law and a Schedule I offense federally. Any future reform would require a new bill in the 133rd Legislature (2027 session) or a citizen ballot initiative — Maine allows citizen initiatives, which advocates have used for cannabis.

What Maine law says now

Title 17-A, §1102(2)(C) lists psilocybin and psilocyn in Schedule X. Section 1107-A(1)(D) classifies unlawful possession of a Schedule X drug as a Class D crime.

The general Class D limits are less than one year of imprisonment and a maximum fine of $2,000. These are maximum authorized penalties, not a prediction of the outcome in any individual case. For a plain-language overview of how Maine treats psychedelic mushrooms versus cannabis, see Are Mushrooms Legal in Maine?.

Federal action is not approval or legalization

Executive Order 14401, signed April 18, 2026, directs federal agencies to support psychedelic research, certain Right to Try pathways, priority review for qualifying products, and possible product-specific rescheduling after Phase 3 trials and FDA approval.

The order does not itself approve a psilocybin product, reschedule psilocybin generally, authorize retail sales, or override Maine criminal law. The FDA's July 2026 public-hearing notice concerns potential future therapeutic use and data standards. A hearing or expedited review is not a drug approval.

The DEA continues to identify psilocybin as a controlled hallucinogen. Federal research developments do not provide a legal path for Maine cannabis licensees to possess, manufacture, advertise, or sell psilocybin.

What Maine cannabis operators should do

• Keep psilocybin outside licensed cannabis premises, inventory, marketing, events, and staff activity.
• Do not describe a study, hearing, voucher, or executive order as FDA approval or legalization.
• Check enacted Maine law and final federal agency action before changing policy. Bill introductions and forecasts are not operative law.
• Use qualified legal counsel for a fact-specific compliance question.

For current cannabis requirements, use the Maine cannabis regulations guide and OCP's official rules rather than treating psychedelic policy as an extension of the cannabis program.